Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunityYared Hailemichael, Adi Diab, Salah-Eddine Bentebibel et al.|Cancer Cell|2022Cited by 338
Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapyNaimah Turner, Roza Nurieva, Sarah Hamidi et al.|Frontiers in Immunology|2024Cited by 11